Independent Associate
 


 
MaxGXL Formulator

Robert Keller MD, MS, FACP, has been named as one of the worlds 2,000 Outstanding Scientists of the 21st Century, and has served on the scientific review panels for the National Institutes of Health and the VA.

more
 


Formulator


Dr. Robert Keller

Robert Keller MD, MS, FACP, has been named as one of the world’s 2,000 Outstanding Scientists of the 21st Century, and has served on the scientific review panels for the National Institutes of Health and the VA.

Robert H. Keller, MD, MS, FACP, AAHIVS
 
Education and Training:
1966 Bachelor of Arts in Biology Master of Science in Biology Fordham University, Bronx, New York
1966 Bachelor of Arts in Biology Master of Science in Biology Fordham University, Bronx, New York
1970 Doctor of Medicine (MD) with honors Temple University, Philadelphia, Pennsylvania
1970-1974 Internship, Resident and Senior Resident University of Rochester, Rochester, New York
1974-1976 Fellow and Senior Fellow Department of Immunology Mayo Clinic, Rochester, Minnesota
1976 Master of Science in Immunology Mayo Graduate School of Medicine Rochester, Minnesota
   
Professional and Faculty Positions:
2006 Founder, CSO and Director of Medicine KBK Institute of Advanced Medicine Hollywood, Florida
2001 Founder, Chairman, CEO & CSO Phoenix BioSciences which has developed a new first in class and first in man viral-host interaction inhibitor for HIV / AIDS
1999 Founder, Chairmain,CEO and CSO Vitimmune, Inc Hollywood, Florida
1998 Voluntary Adjunct Professor Miller School of Medicine, University of Miami Miami, Florida
1996 Chairman and CEO Immune Balance Technologies Hollywood, Florida
1994-2006 Director of Medicine & Research BIODORON Medical Center Hollywood, Florida
1994-1995 Consultant in Immunology and Hematology Health Professionals, Inc and Center for Special Immunology
1992-1995 Director Immune Reconstitution Program Center for Special Immunology
1992-1995 Medical Director Center for Special Immunology Miami Beach, Florida
1987-1996 President and Medical Director The Wilson Bode Center Fort Lauderdale, Florida
1986-1987 Associate Director of Research and Development Coulter Immunology Coulter Electronics, Inc., Hialeah, Florida
1982-1986 Medical Director Wilson Bode Center for Hematology and Immunology Research Milwaukee, Wisconsin
1982-1986 Clinical Professor Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin
1982-1986 Associate Professor Departments of Medicine and Biophysics Medical College of Wisconsin Milwaukee, Wisconsin
1982-1986 Clinical Investigator and Staff Physician Zablocki VAMC Milwaukee, Wisconsin
1980-1982 Director of Immunology Midwest Children's Cancer Center (Immunology, Flow Cytometry, Transplantation) Chief of Immunology Milwaukee Children's Hospital Milwaukee, Wisconsin
1980-1982 Associate Professor Department of Pediatrics (Hematology/Oncology, Immunology) Medical College of Wisconsin Milwaukee, Wisconsin
1979-1982 Clinical Associate Professor Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin
1978-1980 Research Associate and Staff Physician Research Service Zablocki VAMC Milwaukee, Wisconsin
1977-1980 Assistant Professor Department of Medicine (Hematology/Oncology) Medical College of Wisconsin Milwaukee, Wisconsin
1977 Consultant And Assistant Professor Department of Immunology Mayo Medical School Dept. of Medicine University of Minnesota
1974-1977 Fellow and Senior Research Fellow in Immunology Mayo Clinic Foundation Mayo Graduate School of Medicine Rochester, Minnesota
   
Hospital Staff Appointments:
1976-1977 Mayo Clinic, Rochester, Minnesota
1977-1986 Zablocki VAMC, Milwaukee, Wisconsin
1977-1986 Milwaukee County Medical Complex, Milwaukee, Wisconsin
1992-1997 Mount Sinai Medical Center, Miami Beach, Florida
1992-1999 Cleveland Clinic Hospital, Fort Lauderdale, Florida
1992-1999 Miami Heart Institute, Miami Beach, Florida
1997-1999 Palmetto General Hospital, Hialeah, Florida
1997- 2005 South Shore Hospital, Miami Beach, Florida
1997- 2005 Memorial Medical Center, Hollywood, Florida
1992- Broward General Medical Center, Fort Lauderdale, Florida
1997- Hollywood Medical Center, Hollywood, Florida
   
Fellowships and Awards:
1967-1969 Health Professions Scholarship
Temple University School of Medicine
1974-1975 Mayo Foundation Research Fellowship
Mayo Graduate School of Medicine
1975-1978 National Arthritis Foundation Fellowship
1978-1981 VA Career Development Award, Research Associate
1983-1986 VA Career Development Award, Clinical Investigator
   
Grant Support during Academic Tenure
1978-1980 Alpha-fetoprotein Immunoregulation in a Model of Murine Lymphoma Veterans Administration Research Principal Investigator $210,000
1981-1986 Immunoregulatory Dysfunction in Non-Hodgkin's Lymphoma NIH, NCI Principal Investigator $430,000
1982-1986 Immunologic Studies of Environmental Lung Disease NIH (NIAID) Co-Principal Investigator $525,000
1983-1986 VA Career Development Award Clinical Investigator $240,000
1984-1986 Clinical Applications of Laser Flow Cytometry Principal Investigator NIH (RR Shared Equipment Program) $105,609
1984-1987 Immunoregulatory Dysfunction Principal Investigator VA $245,000
1985-1986 Monoclonal Antibodies in the Detection of Cervical Carcinoma Co-Principal Investigator Hillman Foundation $85,000
1986-1987 Isoprinosine Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC Principal Investigator of FDA IND Newport Foundation $125,000
1986-1987 Isoprinosine Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC Principal Investigator of FDA IND Newport Foundation $125,000
 
Honors:
1970 Alpha Omega Alpha Temple University, School of Medicine
1970 Medical Degree with honors Temple University, School of Medicine
1979 Superior Performance Award in Research Veterans Administration
1980 Fellow, American College of Physicians
1991 Who's Who in Science and Technology
1994 Who's Who in the World
1996 Who's Who in Medicine and Science
1998 HIV Medical Professional of the Year PWAC, Broward County, Florida
1999 Humanitarian of the Year National Hemophilia Foundation
2001 2000 Outstanding Scientists of the 21st Century
2002 1000 Great Americans of the 21st Century
2003 America's Top Physicians in Internal Medicine, Immunology and Hematology
2004 Elected to Board of Governors
 
Academy of HIV Medicine of the State of Florida:
2004 AMA Physicians Recognition Award
2005 Greatest Scholars of the Twenty First Century
2006 Health Professional of the Year Invited Lectureships:
1977 Second Fogarty International Conference on Neonatal Liver Disease Baltimore, Maryland
1977 International Conference on the Diagnosis and Prevention of Neural Tube Defects Los Angeles, California
1977 Second International Conference on Diagnostic Immunology Henniker, New Hampshire
1979 Radio immunochemical Detection of Cancer Albuquerque, New Mexico
1980 Visiting Professor of Hematology University of Mississippi Jackson, Mississippi
1981 Visiting Professor of Hematology University of California Irvine, California
1981 Third International Conference on Diagnostic Immunology, Section Chair
1982 Visiting Professor of Pathology University of Texas Medical Branch Galveston, Texas
1983 Visiting Professor of Medicine Wilfred Hall Air Force Research Center Galveston, Texas
1984 Visiting Professor Max Plank Institute for Biochemie Munich, Germany
2005 Visiting Professor of Immunology and Pharmacology Peking Union Medical School (University of Beijing) Beijing, China
 
Editorial Boards:
1986-1990 Diagnostic Immunology
1984-1986 Journal of Leukocyte Biology
2005 Interventions in Aging
 
Reviewer:
1990-Present Journal of Immunology
2005 Interventions in Aging
 
Consultant ships:
Coulter Epics
Coulter Immunology
Corning Scientific
National Aeronautics and Space Administration (NASA)
Abbott HIV Advisory Board
Baxter Advisory Board for Hemophilia
Baxter Advisory Board for Hemophilia Inhibitor Patients
Consultant in Cancer Therapy, PRSS-J, Tokyo, 2005
Medical Advisory Council, American Federation of Hemophilia, 2002
 
Board of Director Appointments:
2006 Member American Academy of HIV Medicine
2006 Member Biosource Therapeutics
2001 Chairman, Phoenix Bioscience
1999 Chairman, VitImmune
1996 Chairman, IBT
 
Scientific Advisory Boards:
2006 Cytodyn Inc
2006 Acthelon Medical
2006 Bioscource Therapeutics
 
Certifications:
National Board of Medical Examiners, 1971 and 1990
American Board of Internal Medicine, 1974
American Academy of HIV Medicine, 2001
American Academy of Anti Aging Medicine 2006
 
Current Medical Licensure:
New York #112195
Wisconsin #19121
Florida #58991
 
Certification:
ACLS 1990
ATLS 1990
 
Professional Societies:
Alpha Omega Alpha
American Association for the Advancement of Science
American Association of Immunologists
American College of Physicians
American Federation of Clinical Research
American Society of Clinical Pathology
American Society of Hematology
International Society of Hematology
International Society of Hematopathology
International Immunocompromised Host Society
International Society of Analytical Cytology
Clinical Cytometry Society
New York Academy of Sciences
Clinical Immunology Society
National Organization for Rare Disorders
American Academy of Anti Aginig Medicine
 
Teaching Experience:
1978-1980 Survey in Basic and Clinical Immunology Department of Medicine Medical College of Wisconsin
1980-1983 Principles of Laser Flow Cytometry Department of Health Sciences University of Wisconsin
1981 Special Topics in Immunology Immunoregulation in Cancer Department of Biology Marquette University
1983-1986 Co-Director Flow Cytometry Program University of Wisconsin Introduction to Flow Cytometric Analysis Principles of Image and Laser Cytometry Hybridomas and Monoclonal Antibodies Laboratory Evaluation of Immunoregulation Clinical Immunophenotyping and DNA Analysis Advanced Cytometry Advanced Cytometric Techniques
 
Invited Professional Lectures:
1979 - Dr. Keller has been the invited speaker at more than 2500 state, regional, National, and international, medical and scientific seminars and workshops In the fields of:

    AIDS and Immunoregulation
    Clinical Immunology
    Chronic Fatigue Syndrome and Fibromyalgia
    Autoimmune Disease and Control of Aberrant Immune Response
    Nutrition and the Immune Response
    Hormones and the Immune Response
    Hepatitis C
    Hemophilia
    Protecting the Immune System Before, During, and After Cancer Therapy.
    Age Management
2000-2002 Host of Today's Health, WAXY 790 and Web streamed at Vitimmune.com and RobKellermd.org
2005-2006 Host of Voice America Web Based Interactive Radio Show, The Path to Wellness and Youth
 
Committee Service:
1985-1986 Veterans Administration Development Research and Committee Clement J. Zablocki
VAMC
1986-1989 VA Oncology Merit Review Board
1984-1986 International Society For Analytical Cytology: Research and Development
1983-1986 Controls & Standards University of Wisconsin: Co Chair Flow Cytometry
1983-1986 National Institutes of Health: Special Immunology Review Council Study Section
1980-1982 Medical College of Wisconsin Faculty Welfare Committee
1980-1982 Animal Care Committee
1982-1986 Flow Cytometry Protocol Committee
1992 Cancer Committee for Hollywood Medical Center
1998 Committee of Ten Thousand Medical Advisory Board
1996 National Hemophilia Federation: Medical Advisory Committee
1994 National Hemophilia Foundation- Florida Chapter Medical Advisory Committee
1994-1997 Mount Sinal Medical Center Cancer Committee
2001 Hollywood Medical Center Cancer Committee
2005 Underwriting Committee ProAssurance Malpractice
2005 AAHIVM Standards of Practice Committee
 
Statement of Research Interest:
HIV: Dissection of the immune perturbations Associated with HIV infection including therapy with experimental immunomodulary agents.
Dissection of the immune perturbations Associated with hemophiliac complication and therapeutic intervention using experimental immunoregulatory agents.
Creation and utilization of unique `designer` monoclonal antibodies for the diagnosis, monitoring, imaging and therapy of human hematologic and solid tumor malignancies.
Immune response and immunoregulation: dissection of the basic human immune response and the roles of cytokines and other regulatory molecules and the demonstration and characterization of aberrant responses in neoplastic and immunologic disease.
Nutritional/ Hormonal Supplementation in Age Management and Immunologic Disease
 
Patents Issued:
R.H. Keller and Dr. X. Wen: Allerg-ease (Patent Number 6,180,106) (2000)
R.H. Keller, D.W. Kirchenbaum: ALL-Immune (Patent Number 6,262,019) (2002)
R.H. Keller, PBS 119 a novel treatment for chronic viral infections (Patent Number 6,734,192) (2004)
 
Patents Pending:
Keller R.H. A novel treatment For Viral Infections (CIP) 2005
Keller RH: An improved method for glutathione production in mammals 2007
Keller RH: A nutritional formula to promote weight loss in mammals
Keller RH: A novel treatment for neurodegenerative diseases
Keller RH: A nutritional formula to improve short term memory function
 
Books:
Keller, R.H. After Thirty, Some Maintenance Is Required-A Practical Guide to Age Management
 
Book Chapters:
Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein: A Potential Regulator of Immune Function. In Diseases of the Liver and Biliary Tract. Javitts, N.NIH, Bethesda, Maryland, pp. 119-134, 1977.
Keller, R.H., Calvinico, N.J., Fink, J.N., and Stevens, J.O.: Immunobiologic Aspects of Primate Hypersensitivity Pneumonitis. In Environmental Toxicology. Dungworth, D.L. (Ed), Academic Press, New York, pp.383-395, 1981.
Keller, R.H., Blake, D.G., Lyman, S. and Siebenlist, R.: The Immunobiology of Human Non-Hodgkin's' Lymphomas. In Clinical Cellular Immunology. Ludered, A. (ed). Humana Press, New York, pp. 213-246, 1982.
Patrick, C.W., Keller, R.H., and Horan, P.K.: Flow Cytometry, Cell Sorting and Hybridomas. American Society Clinical Pathology Press. St. Louis, MO, pp. 1-182, 1982.
Patrick, C.W., Parker, J., Keller, R.H., and Horan, P.K.: The Clinical Utility of Monoclonal Antibodies and Immunophenotyping. In Flow Cytometry and Cell Sorting in Hematologic Disease. American Society of American Pathologists Press. Chicago, IL pp. 1-191.
Calvinico, N.J., Fink, J.N., and Keller, R.H.: Hypersensitivity Pneumonitis. In The Immunology of the Lung. Bienenstock, J. (Ed), Academic Press, New York pp 365-366, 1984
Keller, R.H., Milson, T.J., Janicek, K.M., Patrick, L.C., Sohnle, P., and Patrick, C.W.: Clinical Utilization of the Technicon H-6000 Flow Cytochemical Flow System in Allergy Testing. In Proceedings of the 4th International Technicon Hematology Colloquium. Simson, E. (ed) Academic Press, New York, pp 179- 188, 1984.
Patrick, C.W., Horan, P.K, and Keller, R.H.: Immunophenotypic and Functional Analysis Using Laser Flow Cytometry: Clinical Utility. American Society of Clinical Pathology Press, Chicago, IL, 1985, pp. 1-168.
Patrick, C.W. and Keller, R.H.: Lymphocytes: Biochemistry, Physiology, Function and Morphology. In Principles of Hematology: Clinical and Laboratory Practice. R.L. Bick, (Ed) C.V. Mosby, St. Louis, MO in press.
Patrick, C.W. and Keller, R.H.: The Emerging Role of Laser Flow Cytometry and Monoclonal Antibodies in Clinical Medicine. In: Principles of Hematology: Clinical Laboratory Practice. R.L. Bick (Ed) C.V. Mosby, St. Louis, MO, in press.
Keller, R.H. and Patrick, C.W.: Characterization of the Human Myeloid Series by Monoclonal Antibodies. In Monoclonal Antibodies in Laboratory Medicine. Swartz, M. (Ed) Academic Press, New York, in press.
Patrick, C.W., McFadden, P.W., and Keller, R.H.: Immunophenotypic Analysis of Human Bone Marrow Employing Monoclonal Antibodies and Laser Flow Cytometry. In Proceedings of the Second International Conference on Technological Advances in Laboratory Hematology. Howen, B. (ed),Academic Press, 1985.
Keller, R.H., Janicek, K.M., and Patrick, C.W.: The Clinical Significance of Laser Flow Cytometry DNA Analysis. In Proceedings of the Second International Conference on Technological Advances in Laboratory Hematology. Howen, B. (Ed) Academic Press, New York, 1985.
Keller, R.H., Van Riel, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G, Fletcher, M.A.: Association of Histocompatability Class II Antigens wit the Chronic Fatigue Immune Dysfunction Syndrome. In Clinical Infectious Disease. University of Chicago, Chicago, IL, 1994:18 (Supp 1): S154-6.
Antioxidants and the skin, A Paradigm for aging. Keller, R.H and E Arrayove (in press) 2004. glutathione in Aging and Immunologic Disease. Loss of Gastrointestinal During Aging and Immunologic Disease Both Ed R. Wallace and Mechanisms of Aging Dove Press N Z, 2006
Original Research Contributions and Invited Reviews: Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein, E-Rosette Formation and Tumor Cell Growth. N Engl J Med 293(24): 1265-1266, 1975.
Tomasi, T.B., Dattwyler, R., Murgita, R. and Keller, R.H.: Immunosuppression By Alpha-fetoprotein. Trans Am Assoc Phys. 88:293-298, 1976.
Geubel, A.P., Keller, R.H., Summerkill, W.H.J., Dickson, E.R., Tomasi, T.B. and Shorter, R.G.: Lymphocyte Cytotoxicity and Inhibition Studied with Autologous Liver Cells: Observation in Chronic Acute Liver Disease and the Primary Biliary Cirrhosis Syndrome. Gasterenterol. 71:450-459, 1976.
Keller, R.H. and Clavanico, N.J., and Tomasi, T.B.: Immunosuppressive Properties of AFP: Role of Estrogens. In Onco Developmental Gene Expression. Fichman, W.H. and Sell, S. (eds) Academic Press, New York, p.278, 1976.
Keller, R.H. and Tomasi, T.B.: Synthesis of Alpha-fetoprotein by Murine Lymphoid Cells in Allogenic Reactions. J Exp Med 143:1120, 1976.
Banks, P., Keller, R.H., Li, V.Y. and White, E.B.: Malignant Lymphomas of Plasmablastic Identity: A Neoplasm with Both "Immunoblastic" and Plasma Cell Features. Am J Med 64:609-610, 1978.
Keller, R.H., Atwater, J.S., Martin, R.S. and Tomasi, T.B.: Ataxia Telangiectasia, Immunosuppression and AFP: Is There a Relationship? In Prevention of Neural- Tube Defects. Crandall, B. (ed) Academic Press, New York, pp.27-40, 1978.
Guirgis, H.A., Lynch, H.T., Keller, R.H., Tomasi, T.B., Vandervoorde, J., Brodky, F., Lynch, J., Rankin, L. and Malony, K.: Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein (AFP) in Cancer-Prone Families: Communicable Implications. In Proceeding of the Third Annual Symposium on the Detection and Prevention of Cancer. Part I (2), 1987.
Keller, R.H., Dattwyler, R.J., Harrison, E. and Tomasi, T.B.: Alpha-fetoprotein in Human Lymphoproliferative Disease. J Lab Clin Immunol, 2:93-98, 1979.
Kaplan, H.J., Meredith, T.A., Aeberg, T.M. and Keller, R.H.: Intraocular Reticulum Cell Sarcoma (Histiocytic Lymphoma) in Richter's Syndrome: A Neoplasm of the Immune System. Arch Opthal 98:707-710, 1980.
Keller, R.H., Blake, B.G., Lyman, S. and Siebenlist, R.: ImmunoregulatoryAbnormalities in Chronic Lymphocytic Leukemia. J Lab Clin Immunol 6:201-208, 1981.
Choi, H. and Keller, R.H.: Co-existence of Chronic Lymphocytic Leukemia and Hodgkin's Disease. Cancer 48:48-55, 1981.
Kaplan, H.J., Aeberg, T.M. and Keller, R.H.: Etiology of Recurrent Clinical Uveitis. Ber Dtsch Ophthal Ges 78:159, 1981.
Kaplan, H.J. and Keller, R.H.: Recurrent Clinical Uveitis: Cell Surface Markers on Vitreous Lymphocytes. Arch Ophthal 100:585-592, 1982
Keller, R.H., Fink, J.N., Lyman, S. and Pederson, G.: Suppressor Cells in Asymptomatic Pigeon Breeders. J Clin Immunol 2:46-51, 1982.
Milson, T.J., Grief, D. and Keller, R.H.: The Variable Effect of Cryopreservation on Peripheral Blood Mononuclear Populations. J Clin Lab Immunol 7:205-218, 1982.
Keller, R.H., Calvanico, N.J. and Stevens, J.O.: Hypersensitivity Pneumonitis In Non-human Primates. In Studies on the Relationship of Immunoregulation and Disease Activity. J Immunol 128:116-123, 1982.
Keller, R.H.: Alpha-fetoprotein: Biologic and Clinical Potential. In Tumor Imaging: The Radioimmunochemical Detection of Cancer. Burchiel, S. and Rhodes, B. (eds) Mason Publishing, New York, pp. 179-188, 1982.
Patrick, C.W. and Keller, R.H.: New Techniques in the Diagnosis of Hematopoietic Malignancies: Monoclonal Antibodies, Flow Cytometry and Cell Sorting. Am Soc Clin Pathol Sp Topic Series 20(3)106-109, 1982.
Keller, R.H., Libnoch, J.A., Patrick, C.W., Blake, D.G., Choi, H. and Hanson, R.D.: Fc Gamma Bearing T Cells in Non-Hodgkin's Lymphomas. Diag Immunol 1:27-32, 1983.
Keller, R.H., Feldman, E. and Libnoch, J.A.: Immunoregulatory Abnormalities the Kindred of Waldenstrum's Macroglobulinemia Patients. Am J Hematol 14:15-22, 1983.
Keller, R.H. and Calvanico, N.J.: Suppressor Macro-molecules. Crit Rev Immunol 5(2): 149-199, 1984.
Fudenberg, H.H., Wilson, G.B., Keller, R.H., Metcalf, J.F., Pauling, E.E., Stuart, E.J. and Floyd, E.: Clinical Application of the Leukocyte Migration Inhibition Assay: New Methods for Determining Transfer Factor Potency and for Prediction of Clinical Response. In Proceedings of the IV International Conference on Transfer Factor. Academic Press, New York, pp. 293-310, 1984.
Patrick, C.W. and Keller, R.H.: A Simple Device for the Collection of Cells Sorted by Flow Cytometry: Preservation of Integrity and Viability. Cytometry 5(3):308-311, 1984.
Keller, R.H., Milson, T.J., Janicek, K.M. and Patrick, C.W.: Monoclonal Antibodies: Clinical Utility and the Misunderstood Epitope. Lab Med 15(12):785-802, 1984.
Keller, R.H., Swartz, S.J., Leven, S., Bar Sella, S. and Fink, J.N.: Immunoregulation in Hypersensitivity Pneumonitis: Phenotypic and Functional Studies of Bronchoalveolar Lavage Lymphocytes. Am Rev Resp Dis 130:766- 771, 1984.
Patrick, C.W., Swartz, S.J., Harrison, K.A. and Keller, R.H.: Collection and Preparation of Hemopoietic Cells for Cell Marker Analysis. Lab Med 15(10): 659-665, 1984.
Patrick, C.W., Milson, T.J., McFadden, P.W. and Keller, R.H.: Flow Cytometry and Cell Sorting. Lab Med 15(11):740-745, 1984.
Wilson, G.B., Fudenberg, H.H. and Keller, R.H.: Guidelines for Immunotherapy of Antigen Specific Defects with Transfer Factor. J Clin Lab Immunol 13:51-58, 1984.
Baumann, M.A., Libnoch, J.A., Patrick, C.W., Choi, H. and Keller, R.H.: Prolonged Survival in Richter's Syndrome with Subsequent Re-emergence of Chronic Lymphocytic Leukemia: A Case Report Including Serial Cell Surface Phenotype Analysis. Am J Hematol 20:67-72, 1985.
Marti, G.E., Patrick, C.W., Muirhead, K., Magruder, L., Vail, M., Schuette, W., Keller, R.H., Horan, P.K. and Gralnick, H.R.: Normal Blood Density Gradient Lymphocyte Subset Analysis: In an Inter-Laboratory Flow Cytometric Comparison of 85 Normal Adults. Am J Hematol 20:41-52, 1985.
Milson, T.J., Patrick, C.W., Sohnle, P.G., Patrick, L.C. and Keller, R.H.: Flow Cytochemical Analysis of Atopic Reactions. Diag Immunol 3:182-186, 1986.
Milson, T.J., Patrick, C.W., Torke, N.J. and Keller, R.H.: Holding Media for Cell Surface Phenotyping Analysis, J Immunol Methods 87: 155-159, 186.
Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Immunoregulatory Abnormalities in Myelodysplastic Disorders. Am K Hematol 22:79-86, 1986
Hansen, R.M, Lerner, N., Abrams, R.A., Patrick, C.W., Malik, M.I. and Keller, R.H.: Chronic Lymphocytic Leukemia with Pure Red Cell Aplasia: Laboratory Demonstration of Persistent Leukemia in Spite of Apparent Complete Clinical Remission. Am J Hematol 22:79-86, 1986.
Baumann, M.A., Keller, McFadden, P.W., Libnoch, J.A and Patrick, C.W.: Myeloid Cell Surface Phenotype in Myelodysplasia: Evidence for Abnormal Persistence of an Early Myeloid Differentiation Antigen. Am J Hematol 23:22-26, 1986.
Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Correlation of Numbers of Natural Killer Cells with Clinical Course in Large Cell Lymphoma. Cancer 57:2309-2312, 1986.
Patrick, C.W., Ash, R., Libnoch, J.A. and Keller, R.H.: Clinical Cytometry and Immunophenotyping: I. Flow Cytometric Analysis of Normal Peripheral Blood and Bone Marrow. Path Immunopathol Res 6:64-76, 1987.
Patrick, C.W., Libnoch, J.A., Kallas, G.A. and Keller, R.H.: Sequential Immunophenotypic Studies in Chronic Lymphocytic Leukemia: UCLA Molecular Biology Symposium. Chronic Lymphocytic Leukemia: Recent Progress-Future Directions. R. Gale and K. Rai (eds) Alan R. Liss, New York, 59, 1987.
Keller, R.H., Libnoch, J.A., Kallas, G.A., and Patrick, C.W.: Sequential Evaluation of T Cell Subsets in B-CLL. UCLA Molecular Biology Symposium Chronic Lymphocytic Leukemia: Recent Progress-Future Directions. R. Galeand K. Rai (eds) Alan R. Liss, New York, 59, 1987.
Fudenberg, H.H, Whitten, H.D., Galbraith, G.M.P., Goust, J.M., Patrick, C.W. and Keller, R.H.: Deficiency of 'Interactive' T Cells in Individuals with Recurrent Infection: Effect of DLE-TF Therapy. Am J Med. In Press, 1994.
Keller, R.H., Van Reil, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G. and Fletcher, M.A.: Association of Histocompatability Class II Antigens with the Chronic Fatigue Immune Dysfunction Syndrome. In Clin Inf Disease 1 8(Supp 1): S154-156, 1994.
 
Papers Submitted, In review and/or Revision
Patrick, C.W. and Keller, R.H.: A Comparative Study of Anticoagulants in Cell Surface Maker Phenotyping and Functional Analysis. Am J Clin Pathol.
Keller, R.H., Choi, H., Libnoch, J.A. and Patrick, C.W.: A Natural Murine Model of Non-Hodgkin's Lymphoma. J Immunol (in revision).
Choi, H., Libnoch, J.A., Aimargo, U., Heckman, M. and Keller, R.H.: Castelman's Tumor: Well Differentiated Lymphocytic Lymphoma and Large Cell Lymphoma in a Single Patient. Human Pathol (in revision).
Keller R.H., Wen K